Common Shares Outstanding: The number of class A shares currently held by investors.
Sernova Biotherapeutics Inc. (T.SVA) had Common Shares Outstanding of 159.89M for the most recently reported fiscal quarter, ending 2018-01-31.
| Income Statement Financials | |
-- |
|
-0.61M |
|
-- |
|
-- |
|
-- |
|
-0.61M |
|
-- |
|
-0.61M |
|
-0.61M |
|
-0.61M |
|
-0.61M |
|
-0.61M |
|
-0.61M |
|
-0.61M |
|
-0.60M |
|
159.89M |
|
159.89M |
|
0.00 |
|
0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
2.98M |
|
-- |
|
-- |
|
-- |
|
0.45M |
|
2.53M |
|
2.53M |
|
2.53M |
|
|
Common Shares Outstanding |
159.89M |
| Cash Flow Statement Financials | |
-0.62M |
|
-0.05M |
|
0.40M |
|
2.08M |
|
1.80M |
|
-0.27M |
|
0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.97% |
|
-23.97% |
|
-20.36% |
|
-23.97% |
|
0.02 |
|
-0.00 |
|
-0.00 |
|